-
EP4056594
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4056594
| EP4056594 - COMPOUNDS AND COMPOSITIONS FOR IMMUNOTHERAPY [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 15.11.2024 Database last updated on 18.11.2024 | |
| Former | Request for examination was made Status updated on 17.03.2023 | ||
| Former | The application has been published Status updated on 12.08.2022 | Most recent event Tooltip | 15.11.2024 | Application deemed to be withdrawn | published on 18.12.2024 [2024/51] | Applicant(s) | For all designated states Birdie Biopharmaceuticals, Inc. P.O. Box 10240 4th Floor, Harbour Place 103 South Church Street George Town, Grand Cayman KY1-1002 / KY | [2023/39] |
| Former [2022/37] | For all designated states Birdie Biopharmaceuticals Inc. Sertus Chambers P.O. Box 2547 Cassia Court Camana Bay Grand Cayman / KY | Inventor(s) | 01 /
LI, Lixin Chaoyang, Beijing, 100600 / CN | [2022/37] | Representative(s) | Snaith, James Michael Kilburn & Strode LLP Lacon London 84 Theobalds Road London WC1X 8NL / GB | [N/P] |
| Former [2022/37] | Mitchell, Simon James Murgitroyd & Company London Euston House 24 Eversholt Street London NW1 1AD / GB | Application number, filing date | 22167502.8 | 08.01.2015 | [2022/37] | Priority number, date | CN20141011324 | 10.01.2014 Original published format: CN201410011324 | CN20141011262 | 10.01.2014 Original published format: CN201410011262 | CN20141011362 | 10.01.2014 Original published format: CN201410011362 | [2022/37] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP4056594 | Date: | 14.09.2022 | Language: | EN | [2022/37] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 27.07.2022 | Classification | IPC: | C07K16/28, A61K31/4745, A61K31/708, A61K31/4375, A61K31/444, A61P35/00 | [2022/37] | CPC: |
C07K16/32 (EP,US);
A61K45/06 (US);
A61K47/6803 (EP,US);
A61K47/6849 (EP,US);
A61K47/6851 (EP,US);
A61K47/6855 (EP,US);
A61K47/6857 (EP,US);
A61K47/6863 (EP,US);
A61K47/6871 (EP,US);
A61K47/6889 (EP,US);
A61P1/04 (EP);
A61P1/18 (EP);
A61P11/00 (EP);
A61P13/08 (EP,US);
A61P13/10 (EP,US);
A61P13/12 (EP);
A61P15/00 (EP);
A61P17/00 (EP);
A61P19/08 (EP);
A61P25/00 (EP);
A61P35/00 (EP,US);
A61P35/02 (EP);
A61P37/02 (EP);
A61P43/00 (EP,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/16] |
| Former [2022/37] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Title | German: | VERBINDUNGEN UND ZUSAMMENSETZUNGEN FÜR DIE IMMUNTHERAPIE | [2022/37] | English: | COMPOUNDS AND COMPOSITIONS FOR IMMUNOTHERAPY | [2022/37] | French: | COMPOSÉS ET COMPOSITIONS POUR L'IMMUNOTHÉRAPIE | [2022/37] | Examination procedure | 13.03.2023 | Amendment by applicant (claims and/or description) | 13.03.2023 | Examination requested [2023/16] | 13.03.2023 | Date on which the examining division has become responsible | 01.08.2024 | Application deemed to be withdrawn, date of legal effect [2024/51] | 22.08.2024 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2024/51] | Parent application(s) Tooltip | EP15734849.1 / EP3092256 | Fees paid | Renewal fee | 08.04.2022 | Renewal fee patent year 03 | 08.04.2022 | Renewal fee patent year 04 | 08.04.2022 | Renewal fee patent year 05 | 08.04.2022 | Renewal fee patent year 06 | 08.04.2022 | Renewal fee patent year 07 | 08.04.2022 | Renewal fee patent year 08 | 27.01.2023 | Renewal fee patent year 09 | Penalty fee | Additional fee for renewal fee | 31.01.2024 | 10 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]WO2008079924 (3M INNOVATIVE PROPERTIES CO [US], et al) | by applicant | US4689338 | US4880935 | EP0404097 | US5122368 | WO9301161 | US5226575 | US5229275 | WO9316185 | US5270163 | US5352784 | US5389640 | US5482936 | US5567610 | US5567588 | US5571894 | US5587458 | US5595877 | US5622929 | US5660985 | US5696249 | WO9808856 | US5763177 | US5789163 | US5817785 | US5824805 | US5843732 | US5843653 | US5853984 | US5869046 | US5874218 | US5958691 | US5977089 | US6001577 | US6005087 | US6031086 | US6110929 | US6127533 | US6184364 | US6194425 | US6214345 | US6225460 | US6242246 | US6248516 | US6331539 | US6344318 | US6376190 | US2002064780 | US6399754 | US6403779 | WO0246192 | WO0246193 | WO0246194 | US6451810 | US6458543 | US6458539 | US6465189 | US6482594 | WO02100442 | US2003054360 | US2003087301 | US2003175950 | US2004014779 | WO2004010957 | US2004043923 | US6716583 | US2004072234 | US2004092470 | US2004162309 | US2004192626 | US2005020525 | US2005032733 | US2005069910 | WO2006117217 | US7157452 | US7301027 | US2012141509 | US2012149061 | US8246968 | US2012237977 | US2012288512 | US2013150558 | US8513390 | US8518404 | US2014256922 |